MAI MILAN: Open Payments
NPI 1346915717 · LAWRENCE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,430 in 111 payments from 17 companies in 2025. Trend: 2023 $720 · 2024 $1,117 · 2025 $2,430
Food & beverage: $2,430
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 19 | $490 |
| Indivior Inc. | 24 | $448 |
| Alkermes, Inc. | 7 | $245 |
| Viatris Specialty LLC | 10 | $240 |
| ABBVIE INC. | 12 | $195 |
| Exact Sciences Corporation | 9 | $191 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $165 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| Sumitomo Pharma America, Inc. | 4 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
Products named: BRIXADI, SUBLOCADE, VIVITROL, YUPELRI, VRAYLAR, Kerendia, The Cologuard Plus Collection Kit, REXULTI.
Industry payments across MA — which companies pay providers there.
